c.i. direct blue 1 has been researched along with ng-nitroarginine methyl ester in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, E; Irie, K; Muraki, T; Ogawa, A; Ohba, K; Tsukahara, F; Uchida, Y | 1 |
Fujii, E; Irie, K; Ishida, H; Muraki, T; Wada, K; Yoshioka, T | 1 |
2 other study(ies) available for c.i. direct blue 1 and ng-nitroarginine methyl ester
Article | Year |
---|---|
Tolerance to lipopolysaccharide-induced increase in vascular permeability in mouse skin.
Topics: Animals; Azo Compounds; Blood Pressure; Capillary Permeability; Coloring Agents; Dose-Response Relationship, Drug; Heart Rate; Injections, Subcutaneous; Interleukin-1; Lipopolysaccharides; Male; Mice; NG-Nitroarginine Methyl Ester; Salmonella typhimurium; Skin; Trypan Blue; Tumor Necrosis Factor-alpha | 1996 |
Microvascular permeability change induced by platelet-activating factor is impaired in diabetic mice.
Topics: Animals; Azo Compounds; Capillary Permeability; Coloring Agents; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Glycoconjugates; Guanidines; Hypoglycemic Agents; Indomethacin; Insulin; Male; Methylene Blue; Mice; Mice, Mutant Strains; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Platelet Activating Factor; Skin; Streptozocin; Trypan Blue | 1999 |